Abstract:
The present invention encompasses methods of producing influenza B viruses in cell culture. The influenza B viruses may have desirable characteristics, such as enhanced replication in eggs and may be used, for example, in vaccines and in methods of treatment to protect against influenza B virus infection.
Abstract:
The complete polynucleotide sequence of the human respiratory syncytial virus subgroup B strain 9320 genome is provided. Proteins encoded by this polynucleotide sequence are also provided. Isolated or recombinant RSV (e.g., attenuated recombinant RSV), nucleic acids, and polypeptides, e.g., comprising mutations in the attachment protein G, are also provided, as are immunogenic compositions comprising such isolated or recombinant RSV, nucleic acids, and polypeptides. Related methods are also described.
Abstract:
Polypeptides, polynucleotides, methods, compositions, and vaccines comprising influenza hemagglutinin and neuraminidase variants are provided.
Abstract:
In certain aspects, the present invention provides methods for increasing the replication capacity of influenza viruses in hens' eggs and/or cell culture, recombinant and/or reassortant influenza viruses with increased replication capacity, and immunogenic and vaccine compositions comprising such recombinant and/or reassortant influenza viruses. In other aspects, the invention further provides nucleic acids encoding influenza genes associated with increased replication capacity, expression vectors comprising the nucleic acids of the invention, methods for making influenza viruses with increased replication capacity, and kits useful for practice of the methods.
Abstract:
The complete polynucleotide sequence of the human respiratory syncytial virus subgroup B strain 9320 genome is provided. Proteins encoded by this polynucleotide sequence are also provided. Isolated or recombinant RSV (e.g., attenuated recombinant RSV), nucleic acids, and polypeptides, e.g., comprising mutations in the attachment protein G, are also provided, as are immunogenic compositions comprising such isolated or recombinant RSV, nucleic acids, and polypeptides. Related methods are also described.
Abstract:
The present invention relates to genetically engineered recombinant respiratory syncytial viruses and viral vectors which contain deletions of various viral accessory gene(s) either singly or in combination. In accordance with the present invention, the recombinant respiratory syncytial viral vectors and viruses are engineered to contain complete deletions of the M2-2, NS1, NS2, or SH viral accessory genes or various combinations thereof. In addition, the present invention relates to the attenuation of respiratory syncytial virus by mutagenisis of the M2-1 gene.
Abstract:
The present invention provides an energy storage system, particularly a battery system, that is capable of preventing self from overheating, comprising at least one energy storage unit each having two terminal posts extending outwards from the interior thereof; when there are at least two energy storage units, electrical connection therebetween is achieved by electrical connection elements that bridge the terminal posts of different energy storage units; at least one of the terminal posts and/or the electrical connection elements is in thermal connection with a heat transfer surface enlarging structure made of solid heat conductive materials. The present invention further relates to a method for preventing overheat of an energy storage system.
Abstract:
The present invention discloses an overheat prevention energy storage system preventing self from overheating, comprising a heat dissipating external surface, wherein at least a portion of the external surface is coated with at least one layer of heat dissipation coating of high emissivity. The present invention further discloses a method for preventing overheat of the energy storage system and a method for forming at least one layer of heat dissipation coating of high emissivity onto at least part of an external surface of the energy storage system or assemblies thereof.
Abstract:
Vectors and methods for the production of influenza viruses suitable as recombinant influenza vaccines in cell culture are provided. Bi-directional expression vectors for use in a multi-plasmid influenza virus expression system are provided. Additionally, the invention provides methods of producing influenza viruses with enhanced ability to replicate in embryonated chicken eggs and/or cells (e.g., Vero and/or MDCK) and further provides influenza viruses with enhanced replication characteristics. A method of producing a cold adapted (ca) influenza virus that replicates efficiently at, e.g., 25° C. (and immunogenic compositions comprising the same) is also provided.
Abstract:
A non-noble metal based catalyst includes a compound represented by Formula 1: ZraMbOxNy [Formula 1] where M is at least one element selected from Group 4 elements through Group 12 elements, a is a number in the range of about 1 to about 8, b is a number in the range of 1 to 8, x is a number in the range of about 0.2 to about 32, and y is a number in the range of about 0.2 to about 16. A fuel cell electrode and fuel cell may be formed using the non-noble metal based catalyst.
Abstract translation:非贵金属基催化剂包括由式1表示的化合物:ZraMbO x N y [式1]其中M是选自第4族元素至第12族元素中的至少一种元素,a为约1至约8的数 ,b为1〜8的数,x为约0.2〜约32的数,y为约0.2〜约16的数。燃料电池电极和燃料电池可以 使用非贵金属类催化剂形成。